1. Bax, B.E., Fairbanks, D.L., Bain, M.D., Simmonds, H.A. and Chalmers, R.A. The entrapment of polyethylene glycol-bound adenosine deaminase (Pegademase) in human carrier erythrocytes. Biochem. Soc. Trans. 24: 442S (1996).
2. Herschfield, M.S. Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycolmodified adenosine deaminase (PEG-ADA). Immunodefic. 4: 93–97 (1993).
3. Herschfield, M.S. and Mitchell, B.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In The Molecular and Metabolic Basis of Inherited Disease (ed. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D.) Vol. II, pp1725–1768, McGraw-Hill, New York (1995).
4. Simmonds, H.A. Purine and pyrimidine disorders. In The Inherited Metabolic Diseases. (ed. Holton, J.B.) pp 297-349., Churchill Livingstone, Edinburgh (1994).
5. Sprandel, U., Hubbard, A.R. and Chalmers, R.A. Survival of ‘carrier erythrocytes’ in dogs. Clin. Sci. 59: 7P (1980).